CannTrust Holdings Inc Stock Canadian Securities Exchange
Equities
TRST
CA1378002077
Pharmaceuticals
Sales 2017 | 20.7 28.44 | Sales 2018 | 45.65 62.71 | Capitalization | 508M 698M |
---|---|---|---|---|---|
Net income 2017 | 6M 8.24M | Net income 2018 | -13M -17.86M | EV / Sales 2017 | 31,215,427 x |
Net cash position 2017 | 17.16M 23.58M | Net cash position 2018 | 58M 79.69M | EV / Sales 2018 | 9,864,003 x |
P/E ratio 2017 |
81.5
x | P/E ratio 2018 |
-34.5
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Greg Guyatt
CEO | Chief Executive Officer | - | 19-02-18 |
David Blair
DFI | Director of Finance/CFO | - | 19-09-30 |
Sales & Marketing | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Greg Guyatt
CEO | Chief Executive Officer | - | 19-02-18 |
Dan Hogan
BRD | Director/Board Member | - | 21-03-16 |
1st Jan change | Capi. | |
---|---|---|
+32.48% | 5.8B | |
-26.22% | 3.92B | |
+4.73% | 3.28B | |
-20.86% | 2.77B | |
-11.88% | 2.26B | |
+46.64% | 1.95B | |
-16.71% | 1.52B | |
+44.65% | 1.49B | |
-9.60% | 1.49B |